Top

Published in:

01-08-2007 | Gynecologic Oncology

Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5–Years Experience

Authors: Charles Coutant, MD, Olivier Morel, MD, Yann Delpech, MD, PhD, Serge Uzan, MD, Emile Daraï, MD, PhD, Emmanuel Barranger, MD

Published in: Annals of Surgical Oncology | Issue 8/2007

Abstract

Background

To evaluate the feasibility after 5 years experience of a laparoscopic sentinel node (SN) procedure with combined radioisotopic and patent blue labeling in patients with cervical cancer.

Methods

Sixty-seven patients (median age 48.9 years) with cervical cancer underwent a laparoscopic SN procedure using an endoscopic gamma probe, after both radioactive and patent blue injections. After the procedure, all the patients underwent complete laparoscopic pelvic/para-aortic lymphadenectomy.

Results

At least one SN was identified in 57 patients (85.1%). According to the Stage, the SN identification rate was 91.2% in early-stage cervical cancer and 78.5% in locally advanced cervical cancer. The mean number of SN was 2.3 per patient (range 1–5). A total of 129 SNs were removed. Lymph node metastasis involvement was identified in the 20 SNs (15.5%) from 14 patients (24.6%). Nine of the 14 patients had at least one macrometastases, three patients presented micrometastases in H&S, and two patients presented isolated single cells. Six patients presented a pelvic non-SN involvement including two patients whose SNs were uninvolved. The false-negative SNs rate was 12.5% (two patients out of 16). Both patients have locally advanced cervical cancer.

Conclusion

This study confirms that laparoscopic SN detection with a combination of radiocolloid and patent blue is accurate in patients with early cervical cancer to assess pelvic lymph node status.

Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001; 51:15–36PubMedCrossRef

Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray MF, Podratz KC, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989; 35:130–5PubMedCrossRef

Plentl A, Friedman EA. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 1971; 2:221–3

Pomel C, Atallah D, Le Bouedec G, Rouzier R, Morice P, Castaigne D, et al. Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol 2003; 91:534–9PubMedCrossRef

Steed H, Rosen J, Murphy S, Laframboise D, De Petrillo D, Covens A. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol 2004; 93:588–93PubMedCrossRef

Hertel H, Köhler C, Michels W, Passover M, Tozzi R, Schneider A. Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol 2003; 90:505–11PubMedCrossRef

Nam JH, Kim JH, Kim DY, Kim MK, Yoo HJ, Kim YM, et al. Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer. Gynecol Oncol 2004; 92:277–83PubMedCrossRef

Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer 2003; 97:3003–9PubMedCrossRef

Martinez-Palones JM, Gil-Moreno A, Perez-Benavente MA, Roca I, Xercavins J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004; 92:845–50PubMedCrossRef

10.

Plante M, Renaud MC, Tetu B, Harel F, Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003; 91:494–503PubMedCrossRef

11.

Marchiole P, Buenerd A, Scoazec JY, Dargent D, Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004; 100:2154–9PubMedCrossRef

12.

Shimoyama M, Yamazaki T, Suda T, Hatakeyama K. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer. An immunohistochemical study with CAM 5.2. Dis Colon Rectum 2003; 46:333–9PubMedCrossRef

13.

Liefers GJ, Cleton-Jansen AM, Van de Velde CL, Hermans J, Van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339:223–8PubMedCrossRef

14.

Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2002; 112:197–274

15.

Da Silva AM, De Oliveira Filho RS, Ferreira LM, Saconato H. Relevance of micrometastases detected by reverse transcriptase-polymerase chain reaction for melanoma recurrence: systematic review and meta-analysis. San Paulo Med J 2003; 121:24–7

16.

Blaheta HJ, Schittek B, Breuninger H, Garbe C. Detection of micrometastasis in sentinel nodes of patients with primary cutaneous melanoma. Recent Results Cancer Res 2001;158:137–46PubMed

17.

Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol 2002; 79:224–9PubMedCrossRef

18.

Osaki T, Oyama T, Gu CD, Yamashita T, So T, Takenoyama M, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 2002; 20:2930–6PubMedCrossRef

19.

Shariat SF, Roudier MP, Wilcox GE, Kattan MW, Scardino PT, Vessella RL, et al. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res 2003; 63:4662–70PubMed

20.

Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000; 7:601–8PubMed

21.

Kronberg U, Lopez-Kostner F, Soto G, Zuniga A, Wistuba I, Miranda V, et al. Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival. Dis Colon Rectum 2004; 47:1151–7PubMedCrossRef

22.

Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S. Clinical implication of lymph node micrometastases in patients with colorectal cancer. A case control study. Oncology 1999; 57:276–80

23.

Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of influence of cytokeratin-positive mini micrometastases in “Negative Node” patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Dis Colon Rectum 2003; 46:1021–6PubMedCrossRef

24.

Puig-Tintore LM, Ordi J, Vidal-Sicart S, Lejarcegui JA, Torne A, Pahisa J, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 2003; 88:29–34PubMedCrossRef

25.

Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001;80:139–44PubMedCrossRef

26.

Ikenberg H, Wiegering II, Pfisterer J, Kiechle-Schwarz M, Schmitt B, Sauerbrei W, et al. Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma. Cancer J Sci Am 1996; 2:28–34PubMed

27.

Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001; 357:15–20PubMedCrossRef

28.

American Joint Committee on Cancer. Manual for Staging of Cancer, 4th ed. Philadelphia: JB Lippincott Company, 1992

29.

Querleu D. Laparoscopically assisted radical vaginal hysterectomy. Gynecol Oncol 1993; 51:248–54PubMedCrossRef

30.

Navratil E. Radical vaginal hysterectomy (Schauta-Amreich operation). Clin Obstet Gynecol 1965; 8:676–704PubMedCrossRef

31.

O’Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000; 79:238–43PubMedCrossRef

32.

Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000; 79:411–5PubMedCrossRef

33.

Kamprath S, Possover M, Schneider A. Laparoscopic sentinel lymph node detection in patients with cervical cancer. Am J Obstet Gynecol 2000; 182:1648PubMedCrossRef

34.

Malur S, Krause N, Kohler C, Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 2001; 80:254–7PubMedCrossRef

35.

Lantzsch T, Wolters M, Grimm J, Mende T, Buchmann J, Sliutz G, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 2001; 85:791–4PubMedCrossRef

36.

van Dam PA, Hauspy J, Vanderheyden T, Sonnemans H, Spaepen A, Eggenstein G, et al. Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 2003; 13:182–6PubMedCrossRef

37.

Li B, Zhang WH, Liu L, Wu LY, Zhang R, Li N. Sentinel lymph node identification in patients with early stage cervical cancer undergoing radical hysterectomy and pelvic lymphadenectomy. Chin Med J (Engl) 2004; 117:867–70

38.

Angioli R, Palaia I, Cipriani C, Muzii L, Calcagno M, Gullotta G, et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 2005; 96:504–9PubMedCrossRef

39.

Verheijen RH, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol 2000; 96:135–8PubMedCrossRef

40.

Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002; 20:688–93PubMedCrossRef

41.

Rhim CC, Park JS, Bae SN, Namkoong SE. Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci 2002;17:507–11PubMed

42.

Lambaudie E, Collinet P, Narducci F, Sonoda Y, Papageorgiou T, Carpentier P, et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol 2003; 89:84–7PubMedCrossRef

43.

Chung YA, Kim SH, Sohn HS, Chung SK, Rhim CC, Namkoong SE. Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging 2003; 30:1014–7PubMedCrossRef

44.

Gil-Moreno A, Diaz-Feijoo B, Roca I, Puig O, Perez-Benavente MA, Aguilar I, et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 2005; 96:187–93PubMedCrossRef

45.

Pijpers R, Buist MR, van Lingen A, Dijkstra J, van Diest PJ, Teule GJ, et al. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging 2004; 31:1479–86PubMedCrossRef

46.

Niikura H, Okamura C, Akahira J, Takano T, Ito K, Okamura K, et al. Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol 2004; 94:528–32PubMedCrossRef

47.

Rob L, Strnad P, Robova H, Charvat M, Pluta M, Schlegerova D, et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol 2005; 98:281–8PubMedCrossRef

48.

Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stage IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999; 85:1547–54PubMedCrossRef

49.

Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998; 91:360–3PubMedCrossRef

50.

Lelievre L, Camatte S, Le Frere-belda MA, Kerrou K, Froissart M, Taurelle R, et al. Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cancer 2004; 14:271–8PubMedCrossRef

51.

Di Stefano AB, Acquaviva G, Garozzo G, Barbic M, Cvjeticanin B, Meglic L, et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: A 2-year experience. Gynecol Oncol 2005; 99:671–9PubMedCrossRef

52.

Buist MR, Pijpers RJ, Van Lingen A, Van Diest PJ, Dijkstra J, Kenemans P, et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 2003; 90:290–6PubMedCrossRef

53.

Rocca I, Caresia AP, Gil-Moreno A, Pifarre P, Aguade-Bruix S, Castell-Conesa, et al. Usefulness of sentinel lymph node detection in early stage of cervical cancer. Eur J Nucl Med Mol Imaging 2005; 32:1210–6CrossRef

54.

Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001; 357:15–20PubMedCrossRef

55.

PG, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer 1989; 43:41–44

Title: Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5–Years Experience
Authors: Charles Coutant, MD
Olivier Morel, MD
Yann Delpech, MD, PhD
Serge Uzan, MD
Emile Daraï, MD, PhD
Emmanuel Barranger, MD
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 8/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-007-9424-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5–Years Experience

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2007

Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion

Superiority of Sonographic Hematoma Guided Resection of Mammogram Only Visible Breast Cancer: Wire Localization Should be an Exception—Not the Rule

Preoperative Lymphoscintigraphy Predicts the Successful Identification but Is Not Necessary in Sentinel Lymph Nodes Biopsy in Breast Cancer

Prognostic Factors in Primary Gastric Lymphoma

Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?

Size of Sentinel Node Tumor Deposits and Extent of Axillary Lymph Node Involvement: Which Breast Cancer Patients May Benefit From Less Aggressive Axillary Dissections?